MedTrace Logo

Cohort Construction for Preterm Infants With Growth Retardation and Its Influencing Factors

NCT04817878 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2021-03-26

No results posted yet for this study

Summary

In this cohort, prospective clinical cohort study was used to establish a follow-up cohort of preterm infants with different gestational ages. The regular monitoring indexes of physical development and neuropsychological development of preterm infants from birth to 3 years after birth were collected. The influencing factors of preterm infants' development at different stages were recorded, and the high-risk factors leading to different stages of preterm infants' growth retardation were analyzed.

Conditions

  • Problem With Growth of an Infant

Interventions

COMBINATION_PRODUCT

Developmental assessment

Physical development assessment (head circumference, length, weight), Neurodevelopment assessment at 36 to 40 weeks of correction (GMS assessment, NBNA assessment), neurodevelopment assessment at 18 months, 24 months, and 36 months (ASQ scale, Language assessment, Wei-style scale), audiovisual screening, etc.

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • xiaomei tong, Ph.D. · Peking University Third Hospital

  • yanmei chang, Ph.D. · Peking University Third Hospital

Eligibility

Min Age
24 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04817878 on ClinicalTrials.gov